Preben Bruun-Nyzell

Preben Bruun-Nyzell is an accomplished finance and management professional with extensive experience in leadership roles across multiple companies. Currently serving as Chief Executive Officer at 2N Pharma and 2A Pharma, Preben also holds the position of Chairman of the Board at Apoglyx. Previous roles include Chief Financial Officer at Qatalum and EMAL, along with significant consultancy experience at Disruptive Play FZ-LLC, Arqaam Capital, and PricewaterhouseCoopers. Preben's expertise spans treasury processes and finance consulting, showcasing a solid foundation in these areas. Preben Bruun-Nyzell holds a BBA in Management from Lancaster University, completed in 1994.